Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ActiRhino Spray is an over-the-counter medical device developed by Laboratoires Grimberg for the symptomatic relief of intense sore throat and nasal congestion. Formulated as a hypertonic, film-forming osmotic solution, it contains vegetable-derived glycerol, water, and a complex of plant extracts including ivy leaf (Hedera helix) and blackcurrant (Ribes nigrum), along with essential oils of peppermint, thyme, and rosemary. Upon application, the spray forms a protective, moisturizing barrier on the affected mucosa, mechanically trapping and removing pathogens, inflammatory proteins, and environmental irritants while promoting tissue repair and reducing pain and swelling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ActiRhino Spray.